Literature DB >> 12055606

Leptin: a pivotal mediator of intestinal inflammation in mice.

Britta Siegmund1, Hans Anton Lehr, Giamila Fantuzzi.   

Abstract

BACKGROUND & AIMS: In addition to acting as a regulator of food intake and energy expenditure, leptin can also modulate immune and inflammatory responses. The role of leptin in intestinal inflammation is the focus of the present study.
METHODS: Acute and chronic colitis were induced in leptin-deficient ob/ob or wild-type (WT) mice using dextran sulfate sodium (DSS) or trinitrobenzene sulfonic acid (TNBS). The severity of colitis was evaluated, and possible mechanisms were studied.
RESULTS: Leptin directly stimulates intraepithelial lymphocytes (IELs) and lamina propria mononuclear cells (LPMCs). In the DSS acute model, ob/ob mice exhibited a 72% reduction of colitis severity and spontaneous release of proinflammatory cytokines from the colon compared with WT mice. Replacement of leptin in ob/ob mice converted disease resistance to susceptibility, indicating that leptin deficiency, not obesity, accounts for the resistance to acute DSS-induced colitis. During chronic DSS-induced colitis and TNBS-induced colitis, in addition to reduced disease severity, ob/ob mice exhibited a significant attenuation in intestinal inflammation, accompanied by reduced production of cytokines and chemokines. When compared with WT mice, CD8(+) IELs of ob/ob mice were reduced in number as well as in their ability to synthesize interferon gamma. In addition, LPMCs of ob/ob mice showed increased apoptosis in untreated as well as DSS- or TNBS-treated mice. Phosphorylation of signal transducer and activator of transcription 3 and induction of cyclooxygenase 2 were absent in the colon of DSS-fed ob/ob mice.
CONCLUSIONS: These results show that leptin represents a functional link between the endocrine and immune systems.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055606     DOI: 10.1053/gast.2002.33631

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  90 in total

Review 1.  Adipose tissue and inflammatory bowel disease pathogenesis.

Authors:  Christopher Fink; Iordanes Karagiannides; Kyriaki Bakirtzi; Charalabos Pothoulakis
Journal:  Inflamm Bowel Dis       Date:  2012-03-08       Impact factor: 5.325

2.  Leptin in intestinal inflammation: good and bad gut feelings.

Authors:  G Matarese; R I Lechler
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

3.  Elevated lipopolysaccharide in the colon evokes intestinal inflammation, aggravated in immune modulator-impaired mice.

Authors:  Eunok Im; Franz Martin Riegler; Charalabos Pothoulakis; Sang Hoon Rhee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-21       Impact factor: 4.052

4.  Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation.

Authors:  Sang Hoon Rhee; Eunok Im; Martin Riegler; Efi Kokkotou; Michael O'brien; Charalabos Pothoulakis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

Review 5.  Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?

Authors:  Laurent Peyrin-Biroulet; Mathias Chamaillard; Florent Gonzalez; Elodie Beclin; Cecilia Decourcelle; Laurent Antunes; Jérôme Gay; Christel Neut; Jean-Frédéric Colombel; Pierre Desreumaux
Journal:  Gut       Date:  2006-09-06       Impact factor: 23.059

6.  Effect of intestinal ischemia-reperfusion injury on protein levels of leptin and orexin-A in peripheral blood and central secretory tissues.

Authors:  Ji Lin; Guang-Tao Yan; Xiu-Hua Hao; Lu-Huan Wang; Kai Zhang; Hui Xue
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

Review 7.  Neuropeptides, mesenteric fat, and intestinal inflammation.

Authors:  Iordanes Karagiannides; Charalabos Pothoulakis
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

Review 8.  Three questions about leptin and immunity.

Authors:  Giamila Fantuzzi
Journal:  Brain Behav Immun       Date:  2008-10-25       Impact factor: 7.217

9.  Apolipoprotein A-IV inhibits experimental colitis.

Authors:  Thorsten Vowinkel; Mikiji Mori; Christian F Krieglstein; Janice Russell; Fumito Saijo; Sulaiman Bharwani; Richard H Turnage; W Sean Davidson; Patrick Tso; D Neil Granger; Theodore J Kalogeris
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

10.  Deletion of intestinal epithelial cell STAT3 promotes T-lymphocyte STAT3 activation and chronic colitis following acute dextran sodium sulfate injury in mice.

Authors:  Tara A Willson; Ingrid Jurickova; Margaret Collins; Lee A Denson
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.